MDxHealth SA (NASDAQ:MDXH) Sees Large Growth in Short Interest

MDxHealth SA (NASDAQ:MDXH) saw a large increase in short interest in March. As of March 15th, there was short interest totalling 56,300 shares, an increase of 81.0% from the February 28th total of 31,100 shares. Currently, 0.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 104,100 shares, the days-to-cover ratio is currently 0.5 days.

MDxHealth Trading Down 0.7 %

Shares of MDxHealth stock opened at $1.51 on Monday. The company has a debt-to-equity ratio of 3.14, a quick ratio of 1.45 and a current ratio of 1.54. The company has a fifty day moving average of $1.75 and a 200 day moving average of $1.99. The company has a market capitalization of $71.40 million, a P/E ratio of -0.99 and a beta of 1.37. MDxHealth has a fifty-two week low of $1.35 and a fifty-two week high of $3.50.

MDxHealth (NASDAQ:MDXH) last released its earnings results on Wednesday, February 26th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.07. MDxHealth had a negative return on equity of 1,077.84% and a negative net margin of 49.52%. The firm had revenue of $24.74 million during the quarter, compared to analysts’ expectations of $22.67 million. On average, sell-side analysts anticipate that MDxHealth will post -1.15 earnings per share for the current fiscal year.

Hedge Funds Weigh In On MDxHealth

Hedge funds and other institutional investors have recently modified their holdings of the stock. Maven Securities LTD bought a new position in shares of MDxHealth during the 3rd quarter valued at about $208,000. Oppenheimer & Co. Inc. lifted its position in shares of MDxHealth by 100.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 20,000 shares of the company’s stock worth $47,000 after buying an additional 10,000 shares in the last quarter. Perkins Capital Management Inc. boosted its stake in MDxHealth by 31.6% during the fourth quarter. Perkins Capital Management Inc. now owns 983,475 shares of the company’s stock valued at $2,331,000 after buying an additional 236,100 shares during the last quarter. Geode Capital Management LLC bought a new stake in MDxHealth in the 4th quarter worth approximately $25,000. Finally, Samjo Management LLC raised its holdings in shares of MDxHealth by 130.9% during the 4th quarter. Samjo Management LLC now owns 1,824,312 shares of the company’s stock worth $4,324,000 after acquiring an additional 1,034,312 shares in the last quarter.

About MDxHealth

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.